Literature DB >> 18682013

GPs' approach to insulin prescribing in older patients: a qualitative study.

Gina Agarwal1, Kalpana Nair, Jarold Cosby, Lisa Dolovich, Mitchell Levine, Janusz Kaczorowski, Chris Butler, Sheri Burns.   

Abstract

BACKGROUND: Evidence suggests that insulin is under-prescribed in older people. Some reasons for this include physician's concerns about potential side-effects or patients' resistance to insulin. In general, however, little is known about how GPs make decisions related to insulin prescribing in older people. AIM: To explore the process and rationale for prescribing decisions of GPs when treating older patients with type 2 diabetes. DESIGN OF STUDY: Qualitative individual interviews using a grounded theory approach.
SETTING: Primary care.
METHOD: A thematic analysis was conducted to identify themes that reflected factors that influence the prescribing of insulin.
RESULTS: Twenty-one GPs in active practice in Ontario completed interviews. Seven factors influencing the prescribing of insulin for older patients were identified: GPs' beliefs about older people; GPs' beliefs about diabetes and its management; gauging the intensity of therapy required; need for preparation for insulin therapy; presence of support from informal or formal healthcare provider; frustration with management complexity; and GPs' experience with insulin administration. Although GPs indicated that they would prescribe insulin allowing for the above factors, there was a mismatch in intended approach to prescribing and self-reported prescribing.
CONCLUSION: GPs' rationale for prescribing (or not prescribing) insulin is mediated by both practitioner-related and patient-related factors. GPs intended and actual prescribing varied depending on their assessment of each patient's situation. In order to improve prescribing for increasing numbers of older people with type 2 diabetes, more education for GPs, specialist support, and use of allied health professionals is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682013      PMCID: PMC2566521          DOI: 10.3399/bjgp08X319639

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  11 in total

Review 1.  Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude.

Authors:  T M Wallace; D R Matthews
Journal:  QJM       Date:  2000-06

2.  Evaluation of alternative strategies for optimizing glycemia: progress to date.

Authors:  William T Cefalu
Journal:  Am J Med       Date:  2002-10-28       Impact factor: 4.965

3.  United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

Authors: 
Journal:  Ann Intern Med       Date:  1998-02-01       Impact factor: 25.391

4.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Authors:  M Shichiri; H Kishikawa; Y Ohkubo; N Wake
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

5.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

6.  Diabetes in the elderly: problems of care and service provision.

Authors:  S Croxson
Journal:  Diabet Med       Date:  2002-07       Impact factor: 4.359

Review 7.  The underuse of insulin therapy in North America.

Authors:  Matthew C Riddle
Journal:  Diabetes Metab Res Rev       Date:  2002 Sep-Oct       Impact factor: 4.876

8.  Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

Authors:  C Abraira; J A Colwell; F Q Nuttall; C T Sawin; N J Nagel; J P Comstock; N V Emanuele; S R Levin; W Henderson; H S Lee
Journal:  Diabetes Care       Date:  1995-08       Impact factor: 19.112

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Beliefs and attitudes of persons with diabetes.

Authors:  E C McCord; C Brandenburg
Journal:  Fam Med       Date:  1995-04       Impact factor: 1.756

View more
  12 in total

Review 1.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus.

Authors:  Urmimala Sarkar; Courtney Lyles; Michael Steinman; Elbert S Huang; Howard H Moffet; Rachel A Whitmer; E Margaret Warton; Andrew J Karter
Journal:  J Am Geriatr Soc       Date:  2016-09-19       Impact factor: 5.562

3.  Doctors' perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study.

Authors:  Shane Cullinan; Aoife Fleming; Denis O'Mahony; Cristin Ryan; David O'Sullivan; Paul Gallagher; Stephen Byrne
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

Review 4.  A meta-synthesis of potentially inappropriate prescribing in older patients.

Authors:  Shane Cullinan; Denis O'Mahony; Aoife Fleming; Stephen Byrne
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

5.  Psychosocial information use for clinical decisions in diabetes care.

Authors:  Charles Senteio; Julia Adler-Milstein; Caroline Richardson; Tiffany Veinot
Journal:  J Am Med Inform Assoc       Date:  2019-08-01       Impact factor: 4.497

6.  Perspectives and experiences of health care professionals and patients regarding treatments for type 2 diabetes.

Authors:  Bernard Gauthier; Sumeet R Singh; Adil Virani; Heidi Staples; Ann Colbourne
Journal:  Can Pharm J (Ott)       Date:  2014-01

Review 7.  Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review.

Authors:  Bruno Rushforth; Carolyn McCrorie; Liz Glidewell; Eleanor Midgley; Robbie Foy
Journal:  Br J Gen Pract       Date:  2016-02       Impact factor: 5.386

8.  Shared decision making and patient-centeredness for patients with poorly controlled type 2 diabetes mellitus in primary care-results of the cluster-randomised controlled DEBATE trial.

Authors:  Anja Wollny; Christin Löffler; Eva Drewelow; Attila Altiner; Christian Helbig; Anne Daubmann; Karl Wegscheider; Susanne Löscher; Michael Pentzek; Stefan Wilm; Gregor Feldmeier; Sara Santos
Journal:  BMC Fam Pract       Date:  2021-05-15       Impact factor: 2.497

9.  Physician reasons for nonpharmacologic treatment of hyperglycemia in older patients newly diagnosed with type 2 diabetes mellitus.

Authors:  Elizabeth Marrett; Qiaoyi Zhang; Claudia Kanitscheider; Michael J Davies; Larry Radican; Mark N Feinglos
Journal:  Diabetes Ther       Date:  2012-06-15       Impact factor: 2.945

Review 10.  Choice of therapy in patients with type 2 diabetes inadequately controlled with metformin and a sulphonylurea: a systematic review and mixed-treatment comparison meta-analysis.

Authors:  Brendan McIntosh; Chris Cameron; Sumeet R Singh; Changhua Yu; Lisa Dolovich; Robyn Houlden
Journal:  Open Med       Date:  2012-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.